Table 3.
Multivariate analysis of FH patients
| CVD Patients (%) | |||||||
|---|---|---|---|---|---|---|---|
|
Patients (n = 546) |
No (n = 466) |
Yes (n = 80) |
OR (CI 95%)* | P | Adjusted OR** (CI 95%) | P | |
| FVII | |||||||
| RR | 410 | 350 (75.1) | 60 (75.0) | 1.00 (Reference) | 1.00 (Reference) | ||
| RQ | 127 | 110 (23.6) | 17 (21.3) | 0.89 (0.50 - 1.59) | 0.70 | 0.76 (0.36 - 1.58) | 0.46 |
| 9 | 6 (1.3) | 3 (3.7) | 2.88 (0.70 -11.84) | 0.14 | 3.53 (0.66 - 18.92) | 0.14 | |
| RQ/QQ | 136 | 116 (24.9) | 20 (25.0) | 0.99 (0.58 - 1.72) | 0.98 | 0.89 (0.45 - 1.78) | 0.75 |
| CAD Patients (%) | |||||||
|
Patients (n = 546) |
No (n = 471) |
Yes (n = 75) |
OR (CI 95%)* | P | Adjusted OR** (CI 95%) | P | |
| FVII | |||||||
| RR | 410 | 354 (75.1) | 56 (74.7) | 1.00 (Reference) | 1.00 (Reference) | ||
| RQ | 127 | 111 (23.5) | 16 (21.3) | 0.90 (0.50 - 1.63) | 0.73 | 0.90 (0.43 - 1.87) | 0.77 |
| 9 | 6 (1.4) | 3 (4.0) | 3.12 (0.76 -12.86) | 0.11 | 3.33 (0.64 - 17.24) | 0.15 | |
| RQ/QQ | 136 | 117 (24.9) | 19 (24.3) | 1.02 (0.58 - 1.78) | 0.96 | 1.05 (0.52 - 2.08) | 0.90 |
| PAD Patients (%) | |||||||
|
Patients (n = 546) |
No (n = 534) |
Yes (n = 12) |
OR (CI 95%)* | P | Adjusted OR** (CI 95%) | P | |
| FVII | |||||||
| RR | 410 | 401 (75.1) | 9 (75.0) | 1.00 (Reference) | 1.00 (Reference) | ||
| RQ | 127 | 125 (23.4) | 2 (13.7) | 0.71 (0.15 -3.34) | 0.67 | 0.78 (0.15 - 3.84) | 0.76 |
| 9 | 8 (1.5) | 1 (8.3) | 5.56 (0.63 -49.33) | 0.12 | 5.77 (0.26 - 125.96) | 0.26 | |
| RQ/QQ | 136 | 132 (24.9) | 3 (24.0) | 1.00 (0.27 - 3.77) | 0.99 | 1.03 (0.26 - 4.17) | 0.96 |
*Crude OR obtained by univariate logistic regression analysis. **Multivariate logistic regression adjusted for sex, age, body mass index, xanthomas, arterial hypertension, smoking, diabetes mellitus, LDLc, HDLc and lipid-lowering treatment. FVII: Factor VII. FH: Heterozygous Familial Hypercholesterolemia. CVD: cardiovascular disease. CAD: coronary artery disease. PAD: peripheral artery disease.